Skip to content
healthcare.dev

Nateglinide

NDC 55111-329, Nateglinide, tablet, from Dr. Reddy's Laboratories Limited.

Product NDC
55111-329
Status
Listed
Labeler
Dr. Reddy's Laboratories Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077461
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55111-329 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NATEGLINIDE120 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
55111-329-0155111032901100 TABLET in 1 BOTTLE (55111-329-01)
55111-329-0555111032905500 TABLET in 1 BOTTLE (55111-329-05)
55111-329-305511103293030 TABLET in 1 BOTTLE (55111-329-30)
55111-329-785511103297810 BLISTER PACK in 1 CARTON (55111-329-78) / 10 TABLET in 1 BLISTER PACK (55111-329-79)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f7b28951-76d2-cabd-64a1-b74aa225c6e9

Use it

Look up 55111-329 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55111-329 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55111-329. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.